1. Home
  2. TOVX vs CETX Comparison

TOVX vs CETX Comparison

Compare TOVX & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • CETX
  • Stock Information
  • Founded
  • TOVX 2001
  • CETX 1998
  • Country
  • TOVX United States
  • CETX United States
  • Employees
  • TOVX N/A
  • CETX N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • CETX EDP Services
  • Sector
  • TOVX Health Care
  • CETX Technology
  • Exchange
  • TOVX Nasdaq
  • CETX Nasdaq
  • Market Cap
  • TOVX 4.5M
  • CETX 4.1M
  • IPO Year
  • TOVX 2006
  • CETX 1998
  • Fundamental
  • Price
  • TOVX $0.42
  • CETX $1.18
  • Analyst Decision
  • TOVX Hold
  • CETX
  • Analyst Count
  • TOVX 1
  • CETX 0
  • Target Price
  • TOVX N/A
  • CETX N/A
  • AVG Volume (30 Days)
  • TOVX 1.2M
  • CETX 1.2M
  • Earning Date
  • TOVX 08-11-2025
  • CETX 08-14-2025
  • Dividend Yield
  • TOVX N/A
  • CETX N/A
  • EPS Growth
  • TOVX N/A
  • CETX N/A
  • EPS
  • TOVX N/A
  • CETX N/A
  • Revenue
  • TOVX N/A
  • CETX $76,095,551.00
  • Revenue This Year
  • TOVX N/A
  • CETX $19.77
  • Revenue Next Year
  • TOVX N/A
  • CETX $15.00
  • P/E Ratio
  • TOVX N/A
  • CETX N/A
  • Revenue Growth
  • TOVX N/A
  • CETX 16.50
  • 52 Week Low
  • TOVX $0.37
  • CETX $0.85
  • 52 Week High
  • TOVX $7.15
  • CETX $381.57
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 44.90
  • CETX 42.80
  • Support Level
  • TOVX $0.45
  • CETX $1.12
  • Resistance Level
  • TOVX $0.47
  • CETX $1.45
  • Average True Range (ATR)
  • TOVX 0.04
  • CETX 0.12
  • MACD
  • TOVX 0.00
  • CETX -0.01
  • Stochastic Oscillator
  • TOVX 31.76
  • CETX 17.14

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: